|Bid||0.00 x 1400|
|Ask||0.00 x 1200|
|Day's Range||19.07 - 20.31|
|52 Week Range||17.17 - 35.67|
|Beta (5Y Monthly)||1.84|
|PE Ratio (TTM)||20.29|
|Earnings Date||Oct 26, 2022 - Oct 31, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||21.50|
Subscribe to Yahoo Finance Plus to view Fair Value for MD
Mednax (MD) delivered earnings and revenue surprises of 0% and 1.34%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
FORT LAUDERDALE, Fla., August 04, 2022--Pediatrix Medical Group Reports Second Quarter Results
Mednax (MD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.